Atosiban Improves Implantation and Pregnancy Rates in Patients With Repeated Implantation Failure
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Atosiban, administered at embryo transfer, can improve the implantation rate and the clinical
pregnancy rate in patients with repeated implantation failure undergoing IVF-ET (in-vitro
fertilization and embryo transfer).